EUVIMEDEUVIMED entdecken
Crossref

Preliminary outcomes of stereotactic body radiotherapy in bladder cancer: An initial institutional experience

Trinanjan Basu, Jay Prakash Sahu, Shounak J. Kamat, Rohith R. Menon, Ashay Karpe, Vivek Venkatramani, Sachin Gawde

Advances in Radiotherapy & Nuclear Medicine · 12.05.2026 · 4 (2) · 025290034

DOI: 10.36922/arnm025290034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Radiotherapy & Nuclear Medicine, online erschienen am 12.05.2026. Verfasst von Trinanjan Basu und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Muscle-invasive bladder cancer (MIBC) is commonly managed with radical cystectomy, with systemic therapy when indicated, or with bladder-preserving chemotherapy after maximal transurethral resection of the bladder tumor. However, some patients are not candidates for radical chemoradiotherapy because of comorbidities, poor performance status, or anticipated treatment-related toxicity. MIBC can cause severe hematuria, pain, irritative or obstructive bladder symptoms, and local or systemic disease progression. Stereotactic body radiotherapy (SBRT) has emerged as a curative-intent option in selected disease sites and has gained increasing use in oligometastatic disease. Bladder SBRT, delivered over a shorter treatment course, may improve treatment feasibility and symptom control in selected patients, although published evidence remains limited. We report the preliminary outcomes of our institutional series of SBRT in patients with MIBC and oligometastatic bladder cancer. The initial five patients treated with bladder SBRT included four with MIBC and one with oligometastatic bladder cancer. Treatment was feasible and generally well tolerated, with symptomatic improvement observed in all patients. However, a long follow-up is required to assess the durability of local control and late toxicity.

Zitieren

APA

Basu, T., Sahu, J. P., Kamat, S. J., Menon, R. R., Karpe, A., Venkatramani, V., & Gawde, S. (2026). Preliminary outcomes of stereotactic body radiotherapy in bladder cancer: An initial institutional experience. Advances in Radiotherapy & Nuclear Medicine, 4(2), 025290034. https://doi.org/10.36922/arnm025290034

Vancouver

Basu T, Sahu JP, Kamat SJ, Menon RR, Karpe A, Venkatramani V, et al. Preliminary outcomes of stereotactic body radiotherapy in bladder cancer: An initial institutional experience. Advances in Radiotherapy & Nuclear Medicine. 2026;4(2):025290034. doi:10.36922/arnm025290034

BibTeX
@article{Basu2026,
  author = {Basu, Trinanjan and Sahu, Jay Prakash and Kamat, Shounak J. and Menon, Rohith R. and Karpe, Ashay and Venkatramani, Vivek and Gawde, Sachin},
  title = {Preliminary outcomes of stereotactic body radiotherapy in bladder cancer: An initial institutional experience},
  journal = {Advances in Radiotherapy & Nuclear Medicine},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {025290034},
  doi = {10.36922/arnm025290034}
}
Kostenlos starten →